Sage Journals: Discover world-class research

Abstract

This paper covers the role of clinical pharmacology in the development of safe drugs. The three roles of the clinical pharmacologist are explored. Rational therapeutics—which encompasses risk/benefit assessments, an awareness of the effect of various disease states on pharmacokinetics and pharmacodynamics, and aging —is the basis for the discussion.

Keywords

Rational therapeutics Pharmacokinetics Pharmacodynamics

Get full access to this article

View all access options for this article.

References

Kessler

DA.

Introducing MEDWatch. JAMA. 1993;269:2765–2768.

Gubbins

Bertch

KE.

Drug absorption in gastrointestinal disease and surgery. Clin Pharmacokin. 1991;21:431–447.

Zini

Disease-induced variations in plasma protein levels. Clin Pharmacokin. 1990;19:147–159.

Eller

Effect of hepatic disease on terfenadine and terfenadine metabolite pharmacokinetics. Clin Pharmacol Therapeut. 1993;53:162.

Clinical Pharmacology—Basic Principles in Therapeutics. Chapter 24, 642–720. 3rd Ed. Melmon

Morelli

Hoffman

Nierenberg

, Eds. New York: McGraw Hill; 1992.

Cockcroft

Gault

MH.

Predicting creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.

Lamy

PP.

Physiological changes due to age. Drugs & Aging. 1991;1:385–404.

Clinical Pharmacology—Basic Principles in Therapeutics. Chapter 31, 851–874. 3rd ed. Melmon

Morelli

Hoffman

Nierenberg